China
China biotech IPOs in Hong Kong to stay strong - AVCJ Forum
The frenzy for Chinese biotech developers listing in Hong Kong is expected to continue well into 2022, industry participants told the AVCJ Private Equity & Venture Forum.
China ocular drugs developer raises $63m
China’s Neurophth Biotechnology, a gene therapy developer for ocular diseases, has raised a RMB400 million ($63 million) Series C round led by SDIC China Merchants Investment and Sequoia Capital China.
NetEase music spinout completes $449m Hong Kong IPO
Cloud Village, a music streaming business controlled by Chinese internet giant NetEase and backed by several private equity investors, has raised HK$3.5 billion ($449 million) through a Hong Kong IPO.
China IPOs: The star still wanes
Proceeds from private equity-backed offerings on China’s Star Market are down 75% from their peak one year ago, reflecting ongoing regulatory interference and diminished investor confidence
Investors see China regulatory turbulence as short-term - AVCJ Forum
Regulatory uncertainty overshadowing China's technology sector is a temporary phenomenon, investors told the AVCJ Private Equity & Venture Forum, while noting that targeting areas favored by the government remains a safe play.
Vision Fund adds managing partners in India, China
SoftBank Vision Fund has promoted Sumer Juneja, who heads up its India investments, and Dennis Chang, a China-focused partner, to managing partner level.
Warburg Pincus backs China new materials business
Ambilight, a China-based new materials company focused on electrochromic (EC) components, has raised several hundred million dollars in Series C funding led by Warburg Pincus.
Local turbulence drives China tech players abroad - AVCJ Forum
Regulatory uncertainty in China has encouraged local technology companies to go global rather than rely on a single market, the AVCJ Private Equity & Venture Forum heard.
Xiaomi invests $70m in China LiDAR specialist Hesai
Xiaomi Industrial Investment Fund, a vehicle controlled by smart devices brand Xiaomi, has invested $70 million in Hesai Technology, a China-based developer of sensors used in autonomous driving.
COVID-19 validates sector lens strategies – AVCJ Forum
COVID-19 has reinforced the argument for developing sectoral expertise that spans geographies, industry leaders told the AVCJ Private Equity & Venture Forum.
Ascendent abandons China education take-private
A consortium led by Ascendent Capital Partners has abandoned its planned $230.6 million take-private of Tarena International, a China-based provider of adult professional and K-12 education services.
China's Bits x Bites closes second food tech fund at $100m
Bits x Bites, a Chinese VC firm focused on agriculture and food technology such as alternative protein, has closed its second fund at $100 million, beating a target of $70 million.
CBC, APG launch China healthcare infra fund
Specialist healthcare investor CBC Group has teamed up with APG Asset Management to launch a $1.5 billion fund dedicated to the development of healthcare infrastructure in China.
CMC, Goldman lead $150m round for China's Cyclone Robotics
Cyclone Robotics, a Shanghai-based robotic process automation (RPA) start-up, has raised $150 million in a Series C round led by CMC Capital Group and Goldman Sachs Asset Management.
Vision Fund backs China cleaning robot maker
SoftBank Vision Fund 2 and Capital Today have led a RMB1.2 billion ($188 million) Series C round for Chinese cleaning robot maker Gaussian Robotics.
Centurium invests $100m in China caterer Meican
Centurium Capital has provided a $100 million Series E round for Meican, a Chinese corporate food services company.
China's Red raises $500m at $20b valuation
Chinese social e-commerce app Xiaohongshu, also known as Red, has raised a $500 million round led by Temasek Holdings and Tencent Holdings at a valuation of $20 billion, up from $3 billion in 2018.
China regulation: Shock and awe
A raft of rules, largely targeting the technology sector, has challenged business cases and thwarted exits in China. It is also contributing to tweaks in investment strategy
GL Capital leads $125m round for Hzymes Biotechnology
Wuhan-based Hzymes Biotechnology, a specialized enzymes developer, has raised RMB800 million ($125 million) in Series C funding led by healthcare specialist GL Capital
Hong Kong IPOs: Winner by default
New York’s loss is expected to be Hong Kong’s gain as regulatory and political turbulence drives Chinese start-ups to look for alternative listing destinations – unless valuations become a sticking point
China CRO Tripod raises $156m
Tripod Preclinical Research Laboratories, a China-based contract research organization (CRO) based in Nanjing, has raised RMB1 billion ($156 million) led by Ruihua Capital, Lilly Asia Ventures (LAV) and GL Ventures.
Tiger Global leads $100m round for China HR SaaS player
Moka, a Chinese software-as-a-service (SaaS) provider specializing in human resources services, has raised a $100 million Series C led by Tiger Global Management.